Skip to main content

Advertisement

Log in

Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 04 September 2011

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. American Cancer Society: Breast Cancer Facts & Figures 2009–2010. http://www.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts–figures-2009-2010. Accessed 25 Aug 2011

  2. Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26:768–777

    Article  PubMed  Google Scholar 

  3. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50:613–623

    Article  PubMed  Google Scholar 

  4. Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46:1333–1343

    Article  PubMed  Google Scholar 

  5. Clauw D (2003) The health consequences of the first gulf war. Br Med J 327:1357–1358

    Article  Google Scholar 

  6. Clauw DJ, Engel CC Jr, Aronowitz R, Jones E, Kipen HM, Kroenke K, Ratzan S, Sharpe M, Wessely S (2003) Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med 45:1040–1048

    Article  PubMed  Google Scholar 

  7. Hassett AL, Clauw DJ (2010) The role of stress in rheumatic diseases. Arthritis Res Ther 12:123

    Article  PubMed  Google Scholar 

  8. Mogil JS, Yu L, Basbaum AI (2000) Pain genes?: natural variation and transgenic mutants. Annu Rev Neurosci 23:777–811

    Article  PubMed  CAS  Google Scholar 

  9. Diatchenko L, Slade GD, Nackley AG et al (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135–143

    Article  PubMed  CAS  Google Scholar 

  10. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243

    Article  PubMed  CAS  Google Scholar 

  11. Costigan M, Belfer I, Griffin RS et al (2010) Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 133:2519–2527

    Article  PubMed  Google Scholar 

  12. Tegeder I, Costigan M, Griffin RS et al (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12:1269–1277

    Article  PubMed  CAS  Google Scholar 

  13. Valdes AM, De Wilde G, Doherty SA et al (2011) The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritis. Ann Rheum Dis 70:1556–1561

    Article  PubMed  Google Scholar 

  14. Galvan A, Fladvad T, Skorpen F, Gao X, Klepstad P, Kaasa S, Dragani TA (2011) Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry. Pharmacogenomics J. doi:10.1038/tpj.2011.27

  15. Droney J, Riley J, Ross JR (2011) Evolving knowledge of opioid genetics in cancer pain. Clin Oncol 23:418–428

    Article  CAS  Google Scholar 

  16. Williams DA, Clauw DJ (2009) Understanding fibromyalgia: lessons from the broader pain research community. J Pain 10:777–791

    Article  PubMed  Google Scholar 

  17. Fernandez-de-Las-Penas C, Fernandez-Lao C, Cantarero-Villanueva I, Ambite-Quesada S, Rivas-Martinez I, del Moral-Avila R, Arroyo-Morales M (2011) Catechol-o-methyltransferase genotype (Val158Mmet) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Res Treat (in press)

  18. van Meurs JB, Uitterlinden AG, Stolk L, Kerkhof HJ, Hofman A, Pols HA, Bierma-Zeinstra SM (2009) A functional polymorphism in the catechol-o-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum 60:628–629

    Article  PubMed  Google Scholar 

  19. McLean SA, Diatchenko L, Lee YM et al (2011) Catechol o-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 12:101–107

    Article  PubMed  CAS  Google Scholar 

  20. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M (2008) Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain 138:22–28

    Article  PubMed  Google Scholar 

  21. Dodd MJ, Cho MH, Cooper BA, Miaskowski C (2010) The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 14:101–110

    Article  PubMed  Google Scholar 

  22. Aktas A, Walsh D, Rybicki L (2010) Symptom clusters: myth or reality? Palliat Med 24:373–385

    Article  PubMed  Google Scholar 

  23. Arnold LM, Rosen A, Pritchett YL, D’Souza DN, Goldstein DJ, Iyengar S, Wernicke JF (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119:5–15

    Article  PubMed  CAS  Google Scholar 

  24. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H (2009) Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 146:253–260

    Article  PubMed  CAS  Google Scholar 

  25. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH (2009) The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36:398–409

    Article  PubMed  CAS  Google Scholar 

  26. Thieme K, Gracely RH (2009) Are psychological treatments effective for fibromyalgia pain? Curr Rheumatol Rep 11:443–450

    Article  PubMed  Google Scholar 

  27. Henry NL, Giles JT, Stearns V (2008) Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park) 22:1401–1408

    Google Scholar 

  28. Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, Yann Tsai W, Hershman DL (2010) Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 28:1154–1160

    Article  PubMed  CAS  Google Scholar 

  29. Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, Griggs JJ, Hayes DF (2011) Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms. Cancer. doi:10.1002/cncr.26230

Download references

Acknowledgments

NLH is the Damon Runyon-Lilly Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-53-10).

Disclosures

NLH receives research funding from Eli Lilly, AstraZeneca, and Sanofi Aventis. DJC receives research funding from Forest Laboratories and Merck and is a consultant for Cypress Biosciences, Eli Lilly, Forest Laboratories, Jazz Pharmaceuticals, Merck, Pierre Fabre Pharmaceuticals USA, Pfizer, and UCB.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Lynn Henry.

Additional information

This is an invited commentary to article doi: 10.1007/s10549-011-1757-y

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henry, N.L., Clauw, D.J. Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivors. Breast Cancer Res Treat 133, 413–416 (2012). https://doi.org/10.1007/s10549-011-1804-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1804-8

Keywords

Navigation